Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
22 Results for "
LIR domains
" in MedChemExpress (MCE) Product Catalog:
Products (22)
22 Results for "LIR domains" in MCE Product Catalog:
Cat. No.: HY-161739
CAS No.: 2409960-03-6
YOK-1304 is a p62/Sequestosome-1/SQSTM1 ligand that binds to the p62-ZZ domain. YOK-1304 promotes p62 self-oligomerization and LC3 interaction to facilitate autophagic targeting and p62-dependent selective autophagy. YOK-1304 enhances autophagic flux, induces LC3 puncta formation and p62-LC3 colocalization, and serves as an autophagy-targeting ligand (ATL) that can be linked to target-binding ligands to generate AUTOTAC degraders. YOK-1304 is used in research on cervical cancer and pancreatic cancer .
Cat. No.: HY-P10416
Synonyms: Q14 peptide
Target:
Research Areas:
Cat. No.: HY-P77063
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Rat
Source:
HEK293
Cat. No.: HY-P72521
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P75909
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P75910
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P77062
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Rat
Source:
HEK293
Cat. No.: HY-P78481
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: LILRA5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P72394
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P75912
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Human
Source:
HEK293
Cat. No.: HY-P75914
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Human
Source:
HEK293
Cat. No.: HY-P77064
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P78171
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Human
Source:
HEK293
Cat. No.: HY-P77064A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P75913
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Human
Source:
HEK293
Cat. No.: HY-P78484
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Human
Source:
HEK293
Cat. No.: HY-P78665
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Human
Source:
HEK293
Cat. No.: HY-P78666
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immun
Species:
Human
Source:
HEK293
Cat. No.: HY-P78840
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB3; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 3; Leukocyte Immunoglobulin Like Receptor B3; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3; LIR-3; CD85 Antigen-Like Family Member A; ILT5; Immunoglobulin-Like Transcript 5; LIR3; Monocyte Inhibitory Receptor HL9; CD85a; Leucocyte Ig-Like Receptor B3; PIR-B; ILT-5; PIRB; Leukocyte Immunoglobulin-Like Receptor 3; HL9; CD85a Antigen
Species:
Human
Source:
HEK293
Cat. No.: HY-P704761
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LILRB2; Monocyte/Macrophage Immunoglobulin-Like Receptor 10; Leukocyte Immunoglobulin Like Receptor B2; CD85 Antigen-Like Family Member D; MIR-10; Myeloid Inhibitory Receptor 10; LIR-2; Leucocyte Ig-Like Receptor B2; MIR10; ILT-4; ILT4; Leukocyte Immunoglobulin-Like Receptor 2; LIR2; Immunoglobulin-Like Transcript 4; Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2; Ig-Like Transcript 4; CD85d; CD85d Antigen; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM domains), Member 2
Species:
Human
Source:
HEK293
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
